scispace - formally typeset
Search or ask a question
Author

Aditya K. Padhi

Bio: Aditya K. Padhi is an academic researcher from Indian Institute of Technology Delhi. The author has contributed to research in topics: Angiogenin & Medicine. The author has an hindex of 11, co-authored 40 publications receiving 518 citations.
Topics: Angiogenin, Medicine, Adjuvant, Biology, Epitope

Papers published on a yearly basis

Papers
More filters
Journal ArticleDOI
TL;DR: A new, designed multi-peptide subunit-based epitope vaccine against COVID-19, made up of 33 highly antigenic epitopes from three proteins that have a prominent role in host-receptor recognition, viral entry, and pathogenicity is presented.

150 citations

Journal ArticleDOI
22 Jan 2021-iScience
TL;DR: Using a rational ligand-based interface design complemented with mutational mapping, the authors generated a total of 100,000 mutations and provided insight into the functional outcomes of mutations in the remdesivir-binding site in nsp12 subunit of RdRp.

60 citations

Journal ArticleDOI
TL;DR: A multi-epitope based subunit vaccine using seven important F. gigantica proteins showed potential immunogenic efficacy by elaborating the IFN-γ and humoral response and in silico cloning was performed to create the plasmid construct of vaccine for expression in an appropriate biological system.

57 citations

Posted ContentDOI
29 Mar 2020
TL;DR: This work is presenting a first-of-its-kind, designed multi-peptide subunit based epitope vaccine against COVID-19, made up of 33 highly antigenic epitopes from three proteins that have a prominent role in host receptor recognition, viral entry, and pathogenicity.
Abstract: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and has subsequently spread worldwide. In the absence of any antiviral or immunomodulatory therapies, the disease is spreading at an alarming rate. A possibility of a resurgence of COVID-19 in places where lockdowns have already worked is also developing. Thus, for controlling COVID-19, vaccines may be a better option than drugs. An mRNA-based anti-COVID-19 candidate vaccine has entered a phase 1 clinical trial. However, its efficacy and potency have to be evaluated and validated. Since vaccines have high failure rates, as an alternative, we are presenting a new, designed multi-peptide subunit-based epitope vaccine against COVID-19. The recombinant vaccine construct comprises an adjuvant, cytotoxic T-lymphocyte (CTL), helper T-lymphocyte (HTL), and B-cell epitopes joined by linkers. The computational data suggest that the vaccine is non-toxic, non-allergenic, thermostable, with the capability to elicit a humoral and cell-mediated immune response. The stabilization of the vaccine construct is validated with molecular dynamics simulation studies. This unique vaccine is made up of 33 highly antigenic epitopes from three proteins that have a prominent role in host-receptor recognition, viral entry, and pathogenicity. We advocate this vaccine must be synthesized and tested urgently as a public health priority.

54 citations

Journal ArticleDOI
08 Sep 2020
TL;DR: Prediction and evaluation of mutations at the S-protein receptor-binding domain are essential for understanding the potential development of more pathogenic strains and for COVID-19 management.
Abstract: SARS-CoV-2 has developed a substantial number of mutations, especially in the S-protein. With the advancement of the pandemic, accumulations of further mutations at the S-protein receptor-binding domain could enhance the infectivity and pathogenicity of the virus. Prediction and evaluation of such mutations are essential for understanding the potential development of more pathogenic strains and for COVID-19 management.

53 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: This review is to update the recent discoveries in genetics of ALS, which may provide insight information to help us better understanding of the disease neuropathogenesis.
Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder involving both upper motor neurons (UMN) and lower motor neurons (LMN). Enormous research has been done in the past few decades in unveiling the genetics of ALS, successfully identifying at least fifteen candidate genes associated with familial and sporadic ALS. Numerous studies attempting to define the pathogenesis of ALS have identified several plausible determinants and molecular pathways leading to motor neuron degeneration, which include oxidative stress, glutamate excitotoxicity, apoptosis, abnormal neurofilament function, protein misfolding and subsequent aggregation, impairment of RNA processing, defects in axonal transport, changes in endosomal trafficking, increased inflammation, and mitochondrial dysfunction. This review is to update the recent discoveries in genetics of ALS, which may provide insight information to help us better understanding of the disease neuropathogenesis.

293 citations

Journal ArticleDOI
TL;DR: Overall, a complex picture of lipid–protein interactions emerges, through a range of mechanisms including modulation of the physical properties of the lipid environment, detailed chemical interactions between lipids and proteins, and key functional roles of very specific lipids binding to well-defined binding sites on proteins.
Abstract: Membrane lipids interact with proteins in a variety of ways, ranging from providing a stable membrane environment for proteins to being embedded in to detailed roles in complicated and well-regulated protein functions. Experimental and computational advances are converging in a rapidly expanding research area of lipid–protein interactions. Experimentally, the database of high-resolution membrane protein structures is growing, as are capabilities to identify the complex lipid composition of different membranes, to probe the challenging time and length scales of lipid–protein interactions, and to link lipid–protein interactions to protein function in a variety of proteins. Computationally, more accurate membrane models and more powerful computers now enable a detailed look at lipid–protein interactions and increasing overlap with experimental observations for validation and joint interpretation of simulation and experiment. Here we review papers that use computational approaches to study detailed lipid–prot...

263 citations

Journal ArticleDOI
TL;DR: The individual cases and genome-wide studies that illustrate the association between missense mutations and diseases are reviewed and the current state-of-the-art methodologies that predict the effects of mutations on protein stability, the hydrogen bond network, pH dependence, conformational dynamics and protein function are reported.

238 citations

Journal ArticleDOI
TL;DR: This review summarizes the efforts and achievements in peptide drug discovery, production, and modification, and their current applications and discusses the value and challenges associated with future developments in therapeutic peptides.

202 citations